Author: Mazalovska, Milena; Kouokam, J. Calvin
Title: Lectins as Promising Therapeutics for the Prevention and Treatment of HIV and Other Potential Coinfections Document date: 2018_5_8
ID: 0spmy8vn_33
Snippet: Coronaviruses constitute an important class of human and animal pathogens, and some have been assessed for their susceptibility to lectins. Interestingly, GRFT also prevents SARS coronavirus (SARS-CoV) infection in vitro and in vivo, through specific binding to its spike glycoprotein, and shows activity against multiple other coronaviruses pathogenic to humans, other mammals, and birds; in mice, these inhibitory effects were accompanied with a sp.....
Document: Coronaviruses constitute an important class of human and animal pathogens, and some have been assessed for their susceptibility to lectins. Interestingly, GRFT also prevents SARS coronavirus (SARS-CoV) infection in vitro and in vivo, through specific binding to its spike glycoprotein, and shows activity against multiple other coronaviruses pathogenic to humans, other mammals, and birds; in mice, these inhibitory effects were accompanied with a specific inhibition of deleterious host immune reactions in response to SARS [85] . The Middle East respiratory syndrome coronavirus (MERS-CoV), another highly pathogenic human coronavirus, is inhibited at the entry level by GRFT to prevent infection in vitro [86] . In addition, Hippeastrum hybrid agglutinin (HHA), GNA, Cymbidium agglutinin (CA), and Urtica dioica agglutinin (UDA) demonstrate antiviral activities against coronaviruses in vitro and/or in vivo [67] . In an impressive screening of 33 plant lectins, remarkable antiviral effects on both SARS-CoV and feline infectious peritonitis virus (FIPV) with EC50 values at low g/ml levels were observed, with strongest activities found predominantly among mannosebinding lectins [66] . Based on these data, lectins should be included in antiviral strategies to fight SARS coronavirus infections [87] .
Search related documents:
Co phrase search for related documents- animal human and antiviral effect: 1, 2, 3, 4, 5, 6, 7
- animal human and antiviral strategy: 1
- animal human and Cymbidium agglutinin: 1
- animal human and entry level: 1
- animal human and feline FIPV infectious peritonitis virus: 1, 2, 3, 4, 5, 6
- animal human and FIPV infectious peritonitis virus: 1, 2, 3, 4, 5, 6
- animal human and GNA Hippeastrum HHA hybrid agglutinin: 1
- animal human and HHA hybrid agglutinin: 1
- animal human and highly pathogenic human coronavirus: 1, 2
- animal human and Hippeastrum HHA hybrid agglutinin: 1
- antiviral activity and Cymbidium agglutinin: 1
- antiviral activity and entry level: 1, 2
- antiviral activity and feline FIPV infectious peritonitis virus: 1, 2, 3, 4, 5, 6, 7
- antiviral activity and FIPV infectious peritonitis virus: 1, 2, 3, 4, 5, 6, 7
- antiviral activity and GNA Hippeastrum HHA hybrid agglutinin: 1
- antiviral activity and HHA hybrid agglutinin: 1
- antiviral activity and highly pathogenic human coronavirus: 1, 2, 3, 4, 5, 6
- antiviral effect and FIPV infectious peritonitis virus: 1, 2, 3
- antiviral effect and highly pathogenic human coronavirus: 1
Co phrase search for related documents, hyperlinks ordered by date